Abstracts - faqs.org

Abstracts

Business, international

Search abstracts:
Abstracts » Business, international

DENMARK: CARLSBERG TO INVEST IN BIOTECHNOLOGY

Article Abstract:

The Danish brewery company Carlsberg is planning to invest in biotechnology on a large scale. As part of the brewer operations at Valby has been moved to Fredericia , there are free premises that can be used for incubator activities. Besides laboratory facilities, Carlsberg will raise a venture fund, preferably in co-operation with a strategic partner. Carlsberg has already launched its first biotechnological firm, Cambio, and another three are on the way. Carlsberg also hopes that external biotechnological firms will be attracted to the premises at Valby.

Publisher: A/S Forlaget Borsen
Publication Name: Boersen
Subject: Business, international
ISSN:
Year: 2001

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Denmark: Research centre attracts biotech companies

Article Abstract:

The research centre at Horsholm in Denmark is investing DKr500 million in the next three years, of which DKr240 million will be used next year to build new laboratories and offices for three biotechnology companies: Pharmexa, 7TM Pharma and Exiqon. The dynamic environment in the Nordsjalland region means that several biotechnology companies are waiting in line to enter the research centre. According to Preben Pamsgaard, director of the research centre at Horsholm, the centre will be fully developed within five to six years if the investments keep up at this pace.

Publisher: A/S Forlaget Borsen
Publication Name: Boersen
Subject: Business, international
ISSN:
Year: 2001
Capital expenditures, Research and Testing Services, Scientific Research and Development Services, R&D Facilities, Abstract, Laboratories

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


DENMARK: INDEX VENTURES INTERESTED IN DANISH COMPANIES

Article Abstract:

Index Ventures, the Swiss venture fund, is interested in the Danish biotechnology industry. So far, it has only made one investment - in Genmab - but has cited the Oresund region as its favourite target for future biotechnology investments.

Publisher: A/S Forlaget Borsen
Publication Name: Boersen
Subject: Business, international
ISSN:
Year: 2001
Strategy & planning

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Denmark, Biochemistry, Venture capital companies, Biological products
Similar abstracts:
  • Abstracts: DENMARK: INTER PRIMO'S 2000 RESULTS. Denmark: Vest-Wood plans acquisitions in Germany. DENMARK: NEW WINDOW COMPANY ESTABLISHED
  • Abstracts: DENMARK: CRITICISM OF THE DANISH UMTS BIDDING PROCEDURE. Denmark: UMTS winners on the lookout for partners
  • Abstracts: Denmark: Danfoss to trim down growth forecast. Denmark: Danfoss to relocate production to Mexico
  • Abstracts: Goldman Sachs hampered by culture clash. Focus on tech exports stifles city's economic growth. Red tape ties up the video scene in strict city-state
  • Abstracts: Symbian grabs bigger market share. New rivals invade telecom market. Generation next?
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.